Cognigenics

cognigenics.io

Cognigenics is pioneering RNA-based therapeutics to revolutionize treatment for mental health and neurocognitive disorders. Utilizing patent-pending genetic neuroengineering techniques, the company targets neural networks involved in conditions like anxiety, depression, and cognitive decline. Their innovative approach leverages short hairpin RNA (sh RNA) to mitigate chronic stress effects and improve cognitive functions such as focus and mental clarity. With promising preclinical results indicating high efficacy and safety, Cognigenics aims to transform mental health care by providing long-lasting, non-invasive therapeutic solutions that significantly reduce the burden of these disorders.